Catyalyst Pharmaceutical Partners (CPRX) Tops Q2 EPS by 2c
Tweet
Share
E-mailGet Alerts CPRX Hot Sheet
Price: $31.49 --0%
Financial Fact:
Loss per share - basic and diluted: -0.05
Today's EPS Names:
VIVO, BIOX, PMCB, More
Financial Fact:
Loss per share - basic and diluted: -0.05
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Catyalyst Pharmaceutical Partners (NASDAQ: CPRX) reported Q2 EPS of ($0.05), $0.02 better than the analyst estimate of ($0.07).
For earnings history and earnings-related data on Catyalyst Pharmaceutical Partners (CPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Activist investor presses Xerox to review financial services arm - Bloomberg
- Bernstein SocGen Group Reiterates Outperform Rating on Robinhood Markets (HOOD)
- Avianca secures first of its kind financing from the Brazilian Agency for the Management of Guarantee Funds and Guarantees (ABGF) for Maintenance, Repair and Overhaul (MRO) services at GE Aerospace's
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
